Israel Naval Medical Institute, IDF Medical Corps, Haifa, Israel 31080.
Clin Rheumatol. 2012 May;31(5):795-9. doi: 10.1007/s10067-011-1926-8. Epub 2012 Jan 25.
The association between familial Mediterranean fever (FMF), early atherosclerosis, and electrocardiographic markers for arrhythmias remains controversial. There are conflicting results as to the occurrence of high QT dispersion in FMF. The aim of the present study was to further investigate repolarization dynamics and other repolarization-associated pro-arrhythmogenic markers in FMF patients. To explore repolarization in FMF, patients who responded well to colchicine and patients who had not responded to colchicine, yet were amyloidosis-free, were included. We aimed to evaluate whether increased inflammatory burden, a characteristic of non-responsive patients, was specifically associated with abnormal repolarization. Included in the study were 53 FMF patients (27 colchicine non-responders) and 53 age- and sex-matched control subjects. Electrocardiograms were performed under strict standards. QT variability parameters were computed with custom-made computer software. No significant difference in any of the QT dynamic parameters was found in either FMF group compared with the healthy controls. Mean values of QT variability index, regardless of colchicine response, were similar to previously published results for healthy persons. In conclusion, patients with FMF who are continuously treated with colchicine and have not developed amyloidosis, regardless of their clinical response, have normal QT variability parameters, indicating normal repolarization dynamics and suggesting no increased risk of repolarization-associated cardiac arrhythmias.
家族性地中海热(FMF)、早发性动脉粥样硬化和心律失常的心电图标志物之间的关联仍存在争议。关于 FMF 中 QT 离散度升高的发生存在相互矛盾的结果。本研究的目的是进一步研究 FMF 患者的复极动力学和其他与复极相关的致心律失常标志物。为了探讨 FMF 中的复极,纳入了对秋水仙碱反应良好的患者和对秋水仙碱无反应但无淀粉样变性的患者。我们旨在评估炎症负担的增加(非反应患者的特征)是否与异常复极有特定的相关性。该研究纳入了 53 名 FMF 患者(27 名秋水仙碱无反应者)和 53 名年龄和性别匹配的对照组。根据严格的标准进行心电图检查。使用定制的计算机软件计算 QT 可变性参数。与健康对照组相比,无论是在 FMF 组还是在无反应组,任何 QT 动力学参数均无显著差异。无论秋水仙碱的反应如何,QT 可变性指数的平均值与健康人群的先前发表结果相似。总之,持续接受秋水仙碱治疗且未发生淀粉样变性的 FMF 患者,无论其临床反应如何,其 QT 可变性参数均正常,表明复极动力学正常,提示与复极相关的心律失常风险没有增加。